KRAS and head and neck squamous cell carcinoma: Oncogene activation is a sine qua non of cancer, and thus the LSCC cells that we have examined will certainly express at least one and likely several aberrant oncogenes, although as is typical of SCCHN (Ha and Califano, 2002), none of these cell lines harbour mutations in KRAS (our unpublished data).